scorecardresearch

Strides to acquire PediaCare from Moberg Pharma

Brand acquisition to strengthen consumer healthcare portfolio Strides Shasun has announced that its wholly owned subsidiary Strides Arcolab International, UK has entered into an agreement with Moberg Pharma, Sweden to acquire the ‘PediaCare’ brand for a total consideration of $5 million plus inventory value at closing. PediaCare is an established paediatric cough, cold and allergy […]

Brand acquisition to strengthen consumer healthcare portfolio

Strides Shasun has announced that its wholly owned subsidiary Strides Arcolab International, UK has entered into an agreement with Moberg Pharma, Sweden to acquire the ‘PediaCare’ brand for a total consideration of $5 million plus inventory value at closing.

PediaCare is an established paediatric cough, cold and allergy brand with annual sales of approximately $6 million. PediaCare will form an important part of Strides expanding consumer health care portfolio and brings with it expertise in the paediatric segment as well as a strong brand name with global potential.

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

First published on: 25-11-2016 at 17:34 IST